ARDX (ARDX) Stock Price & Analysis
ARDX (ARDX) rose 1.89% to USD 3.78 as of September 8, 2026 at 06:56 UTC, according to Nexqual real-time market data.
ARDX last closed at USD 3.78; the session ranged USD 3.68–3.78 on volume of 2,982,312 shares. Market capitalization is —, with a 52-week range of USD 3.68–8.4 (NGM). Source: Nexqual, September 8, 2026 at 06:56 UTC.
Key Statistics (as of September 8, 2026 at 06:56 UTC)
| Price | USD 3.78 |
|---|---|
| Change | ▲ 1.89% (up) |
| Previous Close | USD 3.78 |
| Open | USD 3.78 |
| Day Range | USD 3.68 – 3.78 |
| 52-Week Range | USD 3.68 – 8.4 |
| Volume | 2,982,312 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ARDX)
Nexqual's technical model rates ARDX "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:56 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 31.32 (neutral) |
| vs SMA50 | Below (USD 4.62) |
| MACD | -0.26 (negative) |
From ARDX's Latest SEC 10-K Filing (filed 2026-02-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | USD 0.97 | ▼ 0.54% |
| ALDX | Aldeyra Therapeutics, Inc. | USD 1.48 | ▼ 0.67% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| TGTX | TG Therapeutics, Inc. | USD 55.99 | ▼ 1.61% |
| KALA | KALA BIO, Inc. | USD 0.51 | ▼ 3.06% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:56 UTC. This page is informational and not investment advice.